Back to top
more

SONOVA HOLDING (SONVY)

(Delayed Data from OTC)

$56.35 USD

56.35
10,957

+1.07 (1.94%)

Updated Apr 26, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HOLX vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

HOLX vs. SONVY: Which Stock Is the Better Value Option?

HOLX or SONVY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HOLX vs. SONVY: Which Stock Is the Better Value Option?

HOLX vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

HOLX vs. SONVY: Which Stock Is the Better Value Option?

TMO vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

TMO vs. SONVY: Which Stock Is the Better Value Option?

SONVY or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SONVY vs. EW: Which Stock Is the Better Value Option?

SONVY or IDXX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SONVY vs. IDXX: Which Stock Is the Better Value Option?

Here's Why Momentum in SONOVA HOLDING (SONVY) Should Keep going

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, SONOVA HOLDING (SONVY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

SONOVA HOLDING (SONVY) Is a Great Choice for "Trend" Investors, Here's Why

by Zacks Equity Research

SONOVA HOLDING (SONVY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Here's Why Momentum in SONOVA HOLDING (SONVY) Should Keep going

by Zacks Equity Research

SONOVA HOLDING (SONVY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

The Zacks Analyst Blog Highlights: National Vision Holdings, Maravai LifeSciences, Sonova Holding, Sartorius and Henry Schein

by Zacks Equity Research

The Zacks Analyst Blog Highlights: National Vision Holdings, Maravai LifeSciences, Sonova Holding, Sartorius and Henry Schein

Urmimala Biswas headshot

5 MedTech Stocks to Gain in 2021 as Base Business Recovers

by Urmimala Biswas

These five MedTech stocks, EYE, MRVI, SONVY, SARTF and HSIC, all with a favorable Zacks Rank and growth parameters are expected to put up a robust performance in 2021.

Urmimala Biswas headshot

5 Soaring MedTech Stocks to Buy for More Growth in 2021

by Urmimala Biswas

We have selected five MedTech growth stocks with further rooms for improvement in 2021.

Idexx (IDXX) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues

by Zacks Equity Research

Intuitive Surgical (ISRG) posted solid numbers in the third quarter, courtesy of rising customer adoption of procedures and growth in system placements.

    athenahealth (ATHN) Beats Earnings, Misses Revenues in Q3

    by Zacks Equity Research

    athenahealth (ATHN) witnessed a year-over-year increase in Q3 revenues on the back of strength in its Business and Services segment.

      Here's Why Investors Should Sell Patterson Companies Now

      by Zacks Equity Research

      Rapidly changing healthcare environment in the United States, unfavorable price movement, a competitive dental products distribution industry and integration risks pose significant challenges for Patterson Companies (PDCO).

        Here's Why Investors Should Sell Ecolab (ECL) Right Away

        by Zacks Equity Research

        Intensifying competition, foreign exchange volatility, higher raw material costs and integration risks are primary headwinds for Ecolab (ECL) as of now.

          OPKO Health (OPK) Signs New Agreement with Japan Tobacco

          by Zacks Equity Research

          OPKO Health's (OPK) new agreement with Japan Tobacco will enhance prospects of its kidney drug RAYALDEE in Japan.

            Ecolab (ECL) to Divest Equipment Care Segment, Shares Fall

            by Zacks Equity Research

            In August, management at Ecolab (ECL) announced that equipment care business has been witnessing a quiet period, registering just 2% growth on a year-over-year basis in the last quarter.

              Veeva Systems (VEEV) Rides High on Commercial Cloud Platform

              by Zacks Equity Research

              The cost-effectiveness of cloud-based applications over in-premise applications is attracting life science companies. Veeva's (VEEV) industry-specific focus lends it a significant leverage.

                Teleflex (TFX) Hits a 52-Week High on NeoTract Acquisition

                by Zacks Equity Research

                NeoTract acquisition is expected to generate mid-single digit constant currency revenue growth for the next several years and enhance Teleflex's (TFX) margins.

                  PerkinElmer Hits a 52-Week High: What's Driving the Stock?

                  by Zacks Equity Research

                  PerkinElmer's (PKI) portfolio has not only boosted the company's organic growth trajectory but has also helped boost market share worldwide. Solid estimate revision trend boosts investor confidence.

                    AngioDynamicis' (ANGO) Solero MTA System to Drive Growth

                    by Zacks Equity Research

                    Growth in the core Angiographic Catheter business is also likely to fortify the company's footprint in the global space.

                      AngioDynamics (ANGO) Misses on Earnings & Revenues in Q1

                      by Zacks Equity Research

                      AngioDynamics' (ANGO) adjusted gross margin decreased year over year owing to voluntary market withdrawal of the Acculis Microwave Tissue Ablation System.

                        Masimo RAS-45 Full-Market Release to Boost Respiratory Care

                        by Zacks Equity Research

                        Masimo Corporation's (MASI) newly launched RAS-45, a single use adhesive respiration sensor would strengthen the company's foothold in the growing global respiratory care market.